Venomous Snakes

Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose, Fourth Edition

Volumn , Issue , 2007, Pages 399-432

  Walter, Frank G ^a,b   Chase, Peter B ^a,c   Fernández, Miguel C ^d,e   Mcnally, Jude ^a   Borron, Stephen W ^e,f,g  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA MEDICAL CENTER   (United States)

^c Center of El Paso   (United States)

^d Division of Transplant Medicine   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f Forensic Sciences Building   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85158922622     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0693-4.50026-8     Document Type: Chapter

References (200)

1. FE Russell (2001) Toxic effects of terrestrial animal venoms and poisons. CD Klaassen (Eds) Casarett and Doull's Toxicology: The Basic Science of Poisons New York: McGraw-Hill 945-964.
2. RC Dart and J McNally (2001) Efficacy, safety, and use of snake antivenoms in the United States. Ann Emerg Med 37(2), 181-188.
3. J Behler and F King (1995) National Audubon Society Field Guide to North American Reptiles and Amphibians 2nd ed. New York: Alfred A. Knopf
4. FE Russell (1983) Snake Venom Poisoning 2nd ed. Great Neck, NY: Scholium International
5. SP Bush, SM Green, JA Moynihan, et al. (2002) Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri). Ann Emerg Med 40(6), 619-624.
6. WA Watson, TL Litovitz, GC Rodgers Jr, et al. (2003) 2002 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 21(5), 353-421.
7. DA Warrell (1996) Animal toxins. CG Cook (Eds) Manson's Tropical Diseases 20th ed. Philadelphia: WB Saunders 468-515.
8. HM Parrish (1966) Incidence of treated snakebites in the United States. Public Health Rep 81(3), 269-276.
9. WA Wingert and L Chan (1988) Rattlesnake bites in southern California and rationale for recommended treatment. West J Med 148(1), 37-44.
10. HM Parrish, JC Goldner and SL Silberg (1965) Comparison between snakebites in children and adults. Pediatrics 36 251-256.
11. JT Tokish, J Benjamin and F Walter (2001) Crotalid envenomation: the southern Arizona experience. J Orthop Trauma 15(1), 5-9.
12. PE McKinney (2001) Out-of-hospital and interhospital management of crotaline snakebite. Ann Emerg Med 37(2), 168-174.
13. ST Moss, G Bogdan, RC Dart, et al. (1997) Association of rattlesnake bite location with severity of clinical manifestations. Ann Emerg Med 30(1), 58-61.
14. TT Iyaniwura (1991) Snake venom constituents: biochemistry and toxicology (Part 1). Vet Hum Toxicol 33(5), 468-474.
15. TT Iyaniwura (1991) Snake venom constituents: biochemistry and toxicology (Part 2). Vet Hum Toxicol 33(5), 475-480.
16. RL Cate and AL Bieber (1978) Purification and characterization of Mojave (Crotalus scutulatus scutulatus) toxin and its subunits. Arch Biochem Biophys 189(2), 397-408.
17. RR Castilonia, TR Pattabhiraman and FE Russell (1980) Neuromuscular blocking effects of Mojave rattlesnake (Crotalus scutulatus scutulatus) venom. Proc West Pharmacol Soc 23 103-106.
18. P Gopalakrishnakone, BJ Hawgood, SE Holbrooke, et al. (1980) Sites of action of Mojave toxin isolated from the venom of the Mojave rattlesnake. Br J Pharmacol 69(3), 421-431.
19. CL Ho and CY Lee (1981) Presynaptic actions of Mojave toxin isolated from Mojave rattlesnake (Crotalus scutulatus) venom. Toxicon 19(6), 889-892.
20. JJ Valdes, RG Thompson, VL Wolff, et al. (1989) Inhibition of calcium channel dihydropyridine receptor binding by purified Mojave toxin. Neurotoxicol Teratol 11(2), 129-133.
21. JL Glenn and R Straight (1978) Mojave rattlesnake Crotalus scutulatus scutulatus venom: variation in toxicity with geographical origin. Toxicon 16(1), 81-84.
22. JL Glenn, RC Straight, MC Wolfe and DL Hardy (1983) Geographical variation in Crotalus scutulatus scutulatus (Mojave rattlesnake) venom properties. Toxicon 21(1), 119-130.
23. JL Glenn and RC Straight (1989) Intergradation of two different venom populations of the Mojave rattlesnake (Crotalus scutulatus scutulatus) in Arizona. Toxicon 27(4), 411-418.
24. RF Clark, SR Williams, SP Nordt and LV Boyer-Hassen (1997) Successful treatment of crotalid-induced neurotoxicity with a new polyspecific crotalid Fab antivenom. Ann Emerg Med 30(1), 54-57.
25. SA Weinstein, SA Minton and CE Wilde (1985) The distribution among ophidian venoms of a toxin isolated from the venom of the Mojave rattlesnake (Crotalus scutulatus scutulatus). Toxicon 23(5), 825-844.
26. SY Huang, JC Perez, ED Rael, et al. (1992) Variation in the antigenic characteristics of venom from the Mojave rattlesnake (Crotalus scutulatus scutulatus). Toxicon 30(4), 387-396.
27. PW Jansen, RM Perkin and D Van Stralen (1992) Mojave rattlesnake envenomation: prolonged neurotoxicity and rhabdomyolysis. Ann Emerg Med 21(3), 322-325.
28. DL Hardy (1983) Envenomation by the Mojave rattlesnake (Crotalus scutulatus scutulatus) in southern Arizona, U.S.A. Toxicon 21(1), 111-118.
29. DL Hardy (1986) Fatal rattlesnake envenomation in Arizona: 1969–1984. J Toxicol Clin Toxicol 24(1), 1-10.
30. American College of Surgeons Committee on Trauma (1993) Initial assessment and management. Advanced Trauma Life Support Instructor Manual 5th ed. Chicago: American College of Surgeons 17-37.
31. RL Norris and SP Bush (2001) North American venomous reptile bites. PS Auerbach (Eds) Wilderness Medicine 4th ed. St. Louis, MO: Mosby 896-926.
32. FG Walter (1995) Envenomations Dallas, TX: American College of Emergency Physicians
33. CL Ownby, RA Kainer and AT Tu (1974) Pathogenesis of hemorrhage induced by rattlesnake venom: an electron microscopic study. Am J Pathol 76(2), 401-414.
34. JW Dubnoff and FE Russell (1970) Isolation of lethal protein and peptide from Crotalus viridis helleri venom. Proc West Pharmacol Soc 13 98.
35. JB Bjarnason and JW Fox (1994) Hemorrhagic metalloproteinases from snake venoms. Pharmacol Ther 62(3), 325-372.
36. CS Kitchens (1992) Hemostatic aspects of envenomation by North American snakes. Hematol Oncol Clin North Am 6(5), 1189-1195.
37. CS Kitchens and LH Van Mierop (1983) Mechanism of defibrination in humans after envenomation by the Eastern diamondback rattlesnake. Am J Hematol 14(4), 345-353.
38. U Hasiba, LM Rosenbach, D Rockwell and JH Lewis (1975) DIC-like syndrome after envenomation by the snake, Crotalus horridus horridus. N Engl J Med 292(10), 505-507.
39. AZ Budzynski, BV Pandya, RN Rubin, et al. (1984) Fibrinogenolytic afibrinogenemia after envenomation by western diamondback rattlesnake (Crotalus atrox). Blood 63(1), 1-14.
40. TL Simon and TG Grace (1981) Envenomation coagulopathy in wounds from pit vipers. N Engl J Med 305(8), 443-447.
41. DF Mosher (1996) Disorders of blood coagulation. JC Bennett, F Plum (Eds) Cecil Textbook of Medicine 20th ed. Philadelphia: WB Saunders 987-1003.
42. RC Dart (2003) Reptile bites. JE Tintinalli, GD Kelen, JS Stapczynski (Eds) Emergency Medicine: A Comprehensive Study Guide 6th ed. New York: McGraw-Hill 1200-1206.
43. JL Burgess and RC Dart (1991) Snake venom coagulopathy: use and abuse of blood products in the treatment of pit viper envenomation. Ann Emerg Med 20(7), 795-801.
44. RG Bond and KK Burkhart (1997) Thrombocytopenia following timber rattlesnake envenomation. Ann Emerg Med 30(1), 40-44.
45. NG Ahlstrom, W Luginbuhl and CC Tisher (1991) Acute anuric renal failure after pigmy rattlesnake bite. South Med J 84(6), 783-785.
46. HA Reid and RD Theakston (1978) Changes in coagulation effects by venoms of Crotalus atrox as snakes age. Am J Trop Med Hyg 27(5), 1053-1057.
47. VM Gregory, FE Russell, JR Brewer and LR Zawadski (1984) Seasonal variations in rattlesnake venom proteins. Proc West Pharmacol Soc 27 233-236.
48. GR Bond (2001) Controversies in the treatment of pediatric victims of Crotalinae snakebite. Clin Pediatr Emerg Med 2 192-202.
49. AH Schmaier and RW Colman (1980) Crotalocytin: characterization of the timber rattlesnake platelet activating protein. Blood 56(6), 1020-1028.
50. R Gerkin, KC Sergent, SC Curry, et al. (1987) Life-threatening airway obstruction from rattlesnake bite to the tongue. Ann Emerg Med 16(7), 813-816.
51. JV Lewis and CA Portera Jr (1994) Rattlesnake bite of the face: case report and review of the literature. Am Surg 60(9), 681-682.
52. DE Brooks, KA Graeme, AM Ruha and DA Tanen (2002) Respiratory compromise in patients with rattlesnake envenomation. J Emerg Med 23(4), 329-332.
53. SC Curry and DB Kunkel (1985) Toxicology rounds. Death from a rattlesnake bite. Am J Emerg Med 3(3), 227-235.
54. W Banner, FE Russell and B Barton (1984) Fatal rattlesnake bite in a child [Abstract]. Vet Hum Toxicol 26 400.
55. RR Carroll, EL Hall and CS Kitchens (1997) Canebrake rattlesnake envenomation. Ann Emerg Med 30(1), 45-48.
56. RC Dart, KM Hurlbut, R Garcia and J Boren (1996) Validation of a severity score for the assessment of crotalid snakebite. Ann Emerg Med 27(3), 321-326.
57. W Forgey, RL Norris, J Blackman, et al. (1994) Rattlesnake bite. J Wilderness Med 5 216-221.
58. FG Walter and KR Olson (1995) First aid for snakebite. Am Acad Clin Toxicol Update 8(2), 1.
59. DM Howarth, AE Southee and IM Whyte (1994) Lymphatic flow rates and first-aid in simulated peripheral snake or spider envenomation. Med J Aust 161(11–12), 695-700.
60. JL Burgess, RC Dart, NB Egen and M Mayersohn (1992) Effects of constriction bands on rattlesnake venom absorption: a pharmacokinetic study. Ann Emerg Med 21(9), 1086-1093.
61. SK Sutherland, AR Coulter and RD Harris (1979) Rationalisation of first-aid measures for elapid snakebite. Lancet 1(8109), 183-185.
62. SK Sutherland and AR Coulter (1981) Early management of bites by the eastern diamondback rattlesnake (Crotalus adamanteus): studies in monkeys (Macaca fascicularis). Am J Trop Med Hyg 30(2), 497-500.
63. RW Clark (1971) Cryotherapy and corticosteroids in the treatment of rattlesnake bite. Milit Med 136(1), 42-44.
64. RC Dart, D Lindsey and A Schulman (1988) Snakebite and shocks [Letter]. Ann Emerg Med 17 1262.
65. FE Russell (1987) A letter on electroshock for snakebite. Vet Hum Toxicol 29(4), 320-321.
66. EK Johnson, KV Kardong and SP Mackessy (1987) Electric shocks are ineffective in treatment of lethal effects of rattlesnake envenomation in mice. Toxicon 25(12), 1347-1349.
67. NR Howe and JL Meisenheimer Jr (1988) Electric shock does not save snakebitten rats. Ann Emerg Med 17(3), 254-256.
68. RC Dart and RA Gustafson (1991) Failure of electric shock treatment for rattlesnake envenomation. Ann Emerg Med 20(6), 659-661.
69. MB Alberts, M Shalit and F LoGalbo (2004) Suction for venomous snakebite: a study of “mock venom” extraction in a human model. Ann Emerg Med 43(2), 181-186.
70. SP Bush (2004) Snakebite suction devices don't remove venom: they just suck. Ann Emerg Med 43(2), 187-188.
71. SP Bush, KG Hegewald, SM Green, et al. (2000) Effects of a negative pressure venom extraction device (Extractor) on local tissue injury after artificial rattlesnake envenomation in a porcine model. Wilderness Environ Med 11(3), 180-188.
72. SP Bush and DL Hardy Sr (2001) Immediate removal of extractor is recommended. Ann Emerg Med 38(5), 607-608.
73. AC Bronstein, FE Russell, JB Sullivan, et al. (1985) Negative pressure suction in field treatment of rattlesnake bite. [Abstract]. Vet Hum Toxicol 27 297.
74. AC Bronstein, FE Russell, JB Sullivan, et al. (1986) Negative pressure suction in the field treatment of rattlesnake bite victims. Vet Hum Toxicol 28 485.
75. TM Davidson (1988) Intravenous rattlesnake envenomation. West J Med 148(1), 45-47.
76. CS Kitchens, S Hunter and LH Van Mierop (1987) Severe myonecrosis in a fatal case of envenomation by the canebrake rattlesnake (Crotalus horridus atricaudatus). Toxicon 25(4), 455-458.
77. SP Bush and PW Jansen (1995) Severe rattlesnake envenomation with anaphylaxis and rhabdomyolysis. Ann Emerg Med 25(6), 845-848.
78. NS Cruz and RG Alvarez (1994) Rattlesnake bite complications in 19 children. Pediatr Emerg Care 10(1), 30-33.
79. HG Weed (1993) Nonvenomous snakebite in Massachusetts: prophylactic antibiotics are unnecessary. Ann Emerg Med 22(2), 220-224.
80. RF Clark, BS Selden and B Furbee (1993) The incidence of wound infection following crotalid envenomation. J Emerg Med 11(5), 583-586.
81. EJ Goldstein, DM Citron, H Gonzalez, et al. (1979) Bacteriology of rattlesnake venom and implications for therapy. J Infect Dis 140(5), 818-821.
82. RS Horowitz and RC Dart (2001) Antivenins and immunobiologicals: immunotherapeutics of envenomation. PS Auerbach (Eds) Wilderness Medicine: Management of Wilderness and Environmental Emergencies 4th ed. St. Louis, MO: Mosby 952-960.
83. Antivenin (Crotalineae) polyvalent (equine origin). Physician's Desk Reference 49th ed. Montvale, NJ: Medical Economics Data Production Co. 2643-2644.
84. P Consroe, NB Egen, FE Russell, et al. (1995) Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial antivenin for protection against venom-induced lethality in mice. Am J Trop Med Hyg 53(5), 507-510.
85. AM Ruha, SC Curry, M Beuhler, et al. (2002) Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. Ann Emerg Med 39(6), 609-615.
86. RC Dart, SA Seifert, L Carroll, et al. (1997) Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med 30(1), 33-39.
87. EJ Lavonas, CJ Gerardo, G O'Malley, et al. (2004) Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite. Ann Emerg Med 43(2), 200-206.
88. RC Dart, SA Seifert, LV Boyer, et al. (2001) A randomized multicenter trial of Crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med 161(16), 2030-2036.
89. LV Boyer, SA Seifert, RF Clark, et al. (1999) Recurrent and persistent coagulopathy following pit viper envenomation. Arch Intern Med 159(7), 706-710.
90. SR Offerman, SP Bush, JA Moynihan and RF Clark (2002) Crotaline Fab antivenom for the treatment of children with rattlesnake envenomation. Pediatrics 110(5), 968-971.
91. Protherics, Inc. (2000) CroFab, Crotalidae polyvalent immune Fab (Ovine) [Package insert] Nashville, TN: Protherics, Inc.
92. EM Caravati (2004) Copperhead bites and Crotalidae polyvalent immune Fab (ovine): routine use requires evidence of improved outcomes. Ann Emerg Med 43(2), 207-208.
93. EJ Scharman and VD Noffsinger (2001) Copperhead snakebites: clinical severity of local effects. Ann Emerg Med 38(1), 55-61.
94. HM Parrish and CA Carr (1967) Bites by copperheads (Agkistrodon contortrix) in the United States. JAMA 201(12), 927-932.
95. TL Litovitz, W Klein-Schwartz, GC Rodgers Jr, et al. (2002) 2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 20(5), 391-452.
96. LB Schwartz (2004) Systemic anaphylaxis. L Goldman, D Ausiello (Eds) Cecil Textbook of Medicine 22nd ed. Philadelphia: WB Saunders 1614-1617.
97. DN Zull (2000) Anaphylaxis. AL Harwood-Nuss, AB Wolfson, CH Linden, SM Shepherd (Eds) The Clinical Practice of Emergency Medicine 3rd ed. Philadelphia: Lippincott Williams & Wilkins 1053-1057.
98. J Brostoff and T Hall (2001) Hypersensitivity-type I. I Roitt, J Brostoff, D Male (Eds) Immunology 6th ed. Edinburgh, Scotland: Mosby 323-343.
99. GJ Jurkovich, A Luterman, K McCullar, et al. (1988) Complications of Crotalidae antivenin therapy. J Trauma 28(7), 1032-1037.
100. D Spaite, R Dart and JB Sullivan (1988) Skin testing in cases of possible crotalid envenomation. Ann Emerg Med 17(1), 105-106.
101. F Hay and OMR Westwood (2001) Hypersensitivity-type III. I Roitt, J Brostoff, D Male (Eds) Immunology 6th ed. Edinburgh, Scotland: Mosby 357-369.
102. CL Loprinzi, J Hennessee, L Tamsky and TE Johnson (1983) Snake antivenin administration in a patient allergic to horse serum. South Med J 76(4), 501-502.
103. TT Huang, JB Lynch, DL Larson and SR Lewis (1974) The use of excisional therapy in the management of snakebite. Ann Surg 179(5), 598-607.
104. TG Glass Jr (1976) Early debridement in pit viper bites. JAMA 235(23), 2513-2516.
105. SR Garfin, RR Castilonia, SJ Mubarak, et al. (1984) Rattlesnake bites and surgical decompression: results using a laboratory model. Toxicon 22(2), 177-182.
106. RM Stewart, CP Page, WH Schwesinger, et al. (1989) Antivenin and fasciotomy/debridement in the treatment of the severe rattlesnake bite. Am J Surg 158(6), 543-547.
107. SR Garfin, RR Castilonia, SJ Mubarak, et al. (1985) The effect of antivenin on intramuscular pressure elevations induced by rattlesnake venom. Toxicon 23(4), 677-680.
108. SR Garfin, RR Castilonia, SJ Mubarak, et al. (1979) Role of surgical decompression in treatment of rattlesnake bites. Surg Forum 30 502-504.
109. SC Curry, JC Kraner, DB Kunkel, et al. (1985) Noninvasive vascular studies in management of rattlesnake envenomations to extremities. Ann Emerg Med 14(11), 1081-1084.
110. EL Hall (2001) Role of surgical intervention in the management of crotaline snake envenomation. Ann Emerg Med 37(2), 175-180.
111. WF Ganong (2003) Review of Medical Physiology 21st ed. New York: McGraw-Hill
112. NR Frankel and A Villarin (2004) Compartment syndrome evaluation. JR Roberts, JR Hedges (Eds) Clinical Procedures in Emergency Medicine 4th ed. Philadelphia: WB Saunders 1058-1072.
113. AR Hargens, WH Akeson, SJ Mubarak, et al. (1978) Fluid balance within the canine anterolateral compartment and its relationship to compartment syndromes. J Bone Joint Surg Am 60(4), 499-505.
114. TE Whitesides, TC Haney, K Morimoto and H Harada (1975) Tissue pressure measurements as a determinant for the need of fasciotomy. Clin Orthop Rel Res (113), 43-51.
115. SS Zweifach, AR Hargens, KL Evans, et al. (1980) Skeletal muscle necrosis in pressurized compartments associated with hemorrhagic hypotension. J Trauma 20(11), 941-947.
116. RB Heppenstall, AA Sapega, R Scott, et al. (1988) The compartment syndrome. An experimental and clinical study of muscular energy metabolism using phosphorus nuclear magnetic resonance spectroscopy. Clin Orthop Rel Res (226), 138-155.
117. DA Tanen, DC Danish and RF Clark (2003) Crotalidae polyvalent immune Fab antivenom limits the decrease in perfusion pressure of the anterior leg compartment in a porcine crotaline envenomation model. Ann Emerg Med 41(3), 384-390.
118. FA Matsen (1980) Compartmental Syndromes New York: WB Saunders
119. CH Watt Jr (1985) Treatment of poisonous snakebite with emphasis on digit dermotomy. South Med J 78(6), 694-699.
120. JA Guisto (1995) Severe toxicity from crotalid envenomation after early resolution of symptoms. Ann Emerg Med 26(3), 387-389.
121. KM Hurlbut, RC Dart and DW Spaite (1988) Reliability of clinical presentation for predicting significant pit viper envenomation [Abstract]. Ann Emerg Med 17 438.
122. LV Boyer, SA Seifert and JS Cain (2001) Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline Fab antivenom. Ann Emerg Med 37(2), 196-201.
123. RE Hill, GM Bogdan and RC Dart (2001) Time to reconstitution: purified Fab antivenom vs. unpurified IgG antivenom. Toxicon 39(5), 729-731.
124. L Yip (2002) Rational use of crotalidae polyvalent immune Fab (ovine) in the management of crotaline bite. Ann Emerg Med 39(6), 648-650.
125. LS Tyler, ER Fox and EM Caravati (2002) The challenge of drug shortages for emergency medicine. Ann Emerg Med 40(6), 598-602.
126. EE Sanchez, JA Galan, JC Perez, et al. (2003) The efficacy of two antivenoms against the venom of North American snakes. Toxicon 41(3), 357-365.
127. RC Dart, JT McNally, DW Spaite and R Gustafson (1992) The sequelae of pitviper poisoning in the United States. JA Campbell, ED Brody (Eds) Biology of the Pitvipers Tyler, TX: Selva Press 395-404.
128. JP Chippaux (1998) Snakebites: appraisal of the global situation. Bull WHO 76(5), 515-524.
129. RD Theakston, DA Warrell and E Griffiths (2003) Report of a WHO workshop on the standardization and control of antivenoms. Toxicon 41(5), 541-557.
130. A Britt and K Burkhart (1997) Naja naja cobra bite. Am J Emerg Med 15(5), 529-531.
131. BS Gold and P Pyle (1998) Successful treatment of neurotoxic king cobra envenomation in Myrtle Beach, South Carolina. Ann Emerg Med 32(6), 736-738.
132. SA Minton (1996) Bites by non-native venomous snakes in the United States. Wilderness Environ Med 7(4), 297-303.
133. SE Ronan-Bentle, SM Bryant and JB Williams (2004) Naja Kaouthia envenomation in the midwest. Vet Hum Toxicol 46(4), 181-182.
134. BJ Currie (2004) Snakebite in tropical Australia: a prospective study in the “Top End” of the Northern Territory. Med J Aust 181(11–12), 693-697.
135. J Behler and F King (1995) National Audubon Society Field Guide to North American Reptiles and Amphibians 2nd ed. New York: Alfred A. Knopf
136. LK Coelho, E Silva, C Espositto and M Zanin (1992) Clinical features and treatment of Elapidae bites: report of three cases. Hum Exp Toxicol 11(2), 135-137.
137. RC Dart and JB Sullivan (1996) Elapid snake envenomation. AL Harwood-Nuss (Eds) The Clinical Practice of Emergency Medicine Philadelphia: Lippincott-Raven 1453.
138. CS Kitchens and LH Van Mierop (1987) Envenomation by the Eastern coral snake (Micrurus fulvius fulvius). A study of 39 victims. JAMA 258(12), 1615-1618.
139. AR de Roodt, JF Paniagua-Solis, JA Dolab, et al. (2004) Effectiveness of two common antivenoms for North, Central, and South American Micrurus envenomations. J Toxicol Clin Toxicol 42 171.
140. JA Roze (1996) Coral Snakes of the Americas: Biology, Identification, and Venoms Malabar, FL: Krieger
141. HM Parrish and LP Donovan (1964) Facts about snakebites in Alabama. J Med Assoc State Ala 33 297-305.
142. A Alape-Giron, B Stiles, J Schmidt, et al. (1996) Characterization of multiple nicotinic acetylcholine receptor-binding proteins and phospholipases A2 from the venom of the coral snake Micrurus nigrocinctus. FEBS Lett 380(1–2), 29-32.
143. TT Iyaniwura (1991) Snake venom constituents: biochemistry and toxicology (Part 1). Vet Hum Toxicol 33(5), 468-474.
144. TT Iyaniwura (1991) Snake venom constituents: biochemistry and toxicology (Part 2). Vet Hum Toxicol 33(5), 475-480.
145. LC Pettigrew and JP Glass (1985) Neurologic complications of a coral snake bite. Neurology 35(4), 589-592.
146. CY Lee (1970) Elapid neurotoxins and their mode of action. Clin Toxicol 3(3), 457-472.
147. S Norman (1998) Poisindex: Coral Snake Denver, CO: Micromedex
148. JP Rosso, O Vargas-Rosso, JM Gutierrez, et al. (1996) Characterization of alpha-neurotoxin and phospholipase A2 activities from Micrurus venoms. Determination of the amino acid sequence and receptor-binding ability of the major alpha-neurotoxin from Micrurus nigrocinctus nigrocinctus. Eur J Biochem 238(1), 231-239.
149. R Weis and RJ McIsaac (1971) Cardiovascular and muscular effects of venom from coral snake, Micrurus fulvius. Toxicon 9(3), 219-228.
150. HW Ramsey, WJ Taylor, IB Boruchow and GK Snyder (1972) Mechanism of shock produced by an elapid snake (Micrurus f. fulvius) venom in dogs. Am J Physiol 222(3), 782-786.
151. FE Russell (1983) Snake venom poisoning 2nd ed. Great Neck, NY: Scholium International
152. RL Norris and RC Dart (1989) Apparent coral snake envenomation in a patient without visible fang marks. Am J Emerg Med 7(4), 402-405.
153. T Moseley (1966) Coral snake bite: recovery following symptoms of respiratory paralysis. Ann Surg 163(6), 943-948.
154. GG Gaar (1996) Assessment and management of coral and other exotic snake envenomations. J Fla Med Assoc 83(3), 178-182.
155. N McCollough and JF Gennaro Jr (1963) Coral snake bites in the United States. J Fla Med Assoc 49 968-972.
156. HM Parrish and MS Khan (1967) Bites by coral snakes: report of 11 representative cases. Am J Med Sci 253(5), 561-568.
157. SK Sutherland, AR Coulter and RD Harris (1979) Rationalisation of first-aid measures for elapid snakebite. Lancet 1(8109), 183-185.
158. PE McKinney (2001) Out-of-hospital and interhospital management of crotaline snakebite. Ann Emerg Med 37(2), 168-174.
159. BT German, JB Hack, K Brewer and WJ Meggs (2005) Pressure-immobilization bandages delay toxicity in a porcine model of eastern coral snake (Micrurus fulvius fulvius) envenomation. Ann Emerg Med 45(6), 603-608.
160. V Arce, E Rojas, CL Ownby, et al. (2003) Preclinical assessment of the ability of polyvalent (Crotalinae) and anticoral (Elapidae) antivenoms produced in Costa Rica to neutralize the venoms of North American snakes. Toxicon 41(7), 851-860.
161. MS Wisniewski, RE Hill, JM Havey, et al. (2003) Australian tiger snake (Notechis scutatus) and Mexican coral snake (Micrurus species) antivenoms prevent death from United States coral snake (Micrurus fulvius fulvius) venom in a mouse model. J Toxicol Clin Toxicol 41(1), 7-10.
162. JE Soskis (1994) Snakebite Assessment and Treatment in the Eastern United States Midway, FL: Snakebite Publishing
163. American Zoo and Aquarium Association (1999) The Antivenom Index Baltimore, MD: American Zoo and Aquarium Association
164. HS Bawaskar (2004) Snake venoms and antivenoms: critical supply issues. J Assoc Physicians India 52 11-13.
165. D McNamee (2001) Tackling venomous snake bites worldwide. Lancet 357(9269), 1680.
166. AC Cheng and K Winkel (2001) Call for global snakebite control and procurement funding. Lancet 357(9262), 1132.
167. R Fernando (2002) The National Poisons Information Centre in Sri Lanka: the first ten years. J Toxicol Clin Toxicol 40(5), 551-555.
168. TM Davidson, S Schafer and J Killfoil (1995) Cobras. Wilderness Environ Med 6(2), 203-219.
169. G Watt, L Padre, L Tuazon, et al. (1988) Bites by the Philippine cobra (Naja naja philippinensis): prominent neurotoxicity with minimal local signs. Am J Trop Med Hyg 39(3), 306-311.
170. HS Bawaskar and PH Bawaskar (2004) Envenoming by the common krait (Bungarus caeruleus) and Asian cobra (Naja naja): clinical manifestations and their management in a rural setting. Wilderness Environ Med 15(4), 257-266.
171. NH Tan and CS Tan (1988) A comparative study of cobra (Naja) venom enzymes. Comp Biochem Physiol B 90(4), 745-750.
172. R Doley and AK Mukherjee (2003) Purification and characterization of an anticoagulant phospholipase A(2) from Indian monocled cobra (Naja kaouthia) venom. Toxicon 41(1), 81-91.
173. MA Omran and IM Abdel-Nabi (1997) Changes in the arterial blood pressure, heart rate and normal ECG parameters of rat after envenomation with Egyptian cobra (Naja haje) venom. Hum Exp Toxicol 16(6), 327-333.
174. LA Ferguson, A Morling, C Moraes and R Baker (2002) Investigation of coagulopathy in three cases of tiger snake (Notechis ater occidentalis) envenomation. Pathology 34(2), 157-161.
175. DG Lalloo, AJ Trevett, J Black, et al. (1996) Neurotoxicity, anticoagulant activity and evidence of rhabdomyolysis in patients bitten by death adders (Acanthophis sp.) in southern Papua New Guinea. QJM 89(1), 25-35.
176. AL Harvey (2001) Twenty years of dendrotoxins. Toxicon 39(1), 15-26.
177. LT Potter (2001) Snake toxins that bind specifically to individual subtypes of muscarinic receptors. Life Sci 68(22–23), 2541-2547.
178. KN Bradley (2000) Muscarinic toxins from the green mamba. Pharmacol Ther 85(2), 87-109.
179. SW Munday, SR Williams and RF Clark (2003) Dendrotoxin poisoning in a neurobiochemist. J Toxicol Clin Toxicol 41(2), 163-165.
180. BJ Currie (2000) Clinical toxicology: a tropical Australian perspective. Ther Drug Monit 22(1), 73-78.
181. BS Gold (1996) Neostigmine for the treatment of neurotoxicity following envenomation by the Asiatic cobra. Ann Emerg Med 28(1), 87-89.
182. DZ Hung, MY Liau and SY Lin-Shiau (2003) The clinical significance of venom detection in patients of cobra snakebite. Toxicon 41(4), 409-415.
183. RS Blaylock (1999) Antibiotic use and infection in snakebite victims. S Afr Med J 89(8), 874-876.
184. KR Kerrigan, BL Mertz, SJ Nelson and JD Dye (1997) Antibiotic prophylaxis for pit viper envenomation: prospective, controlled trial. World J Surg 21(4), 369-373.
185. F LoVecchio, J Klemens, S Welch and R Rodriguez (2002) Antibiotics after rattlesnake envenomation. J Emerg Med 23(4), 327-328.
186. HG Weed (1993) Nonvenomous snakebite in Massachusetts: prophylactic antibiotics are unnecessary. Ann Emerg Med 22(2), 220-224.
187. P Terry and K Mackway-Jones (2002) Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Antibiotics in nonvenomous snakebite. Emerg Med J 19(2), 142.
188. A Chattopadhyay, RD Patra, V Shenoy, et al. (2004) Surgical implications of snakebites. Indian J Pediatr 71(5), 397-399.
189. C Pochanugool, S Limthongkull and K Meemano (1987) Clinical features of 37 non-antivenin treated neurotoxic snake bite patients. P Gopalakrishnakone, CK Tan (Eds) Progress in Venom and Toxin Research Singapore: Faculty of Medicine, National University of Singapore 46-51.
190. HS Bawaskar and PH Bawaskar (2002) Aphasia in a farmer after viper bite. Lancet 360(9346), 1703.
191. AP Premawardhena, CE de Silva, MM Fonseka, et al. (1999) Low dose subcutaneous adrenaline to prevent acute adverse reactions to antivenom serum in people bitten by snakes: randomised, placebo controlled trial. BMJ 318 1041-1043.
192. IB Gawarammana, SA Kularatne, WP Dissanayake, et al. (2004) Parallel infusion of hydrocortisone +/– chlorpheniramine bolus injection to prevent acute adverse reactions to antivenom for snakebites. Med J Aust 180(1), 20-23.
193. G Watt, RD Theakston, CG Hayes, et al. (1986) Positive response to edrophonium in patients with neurotoxic envenoming by cobras (Naja naja philippinensis). A placebo-controlled study. N Engl J Med 315(23), 1444-1448.
194. G Watt, BD Meade, RD Theakston, et al. (1989) Comparison of Tensilon and antivenom for the treatment of cobra-bite paralysis. Trans R Soc Trop Med Hyg 83(4), 570-573.
195. Tin-Myint, Rai-Mra, Maung-Chit, et al. (1991) Bites by the king cobra (Ophiophagus hannah) in Myanmar: successful treatment of severe neurotoxic envenoming. QJM 80(293), 751-762.
196. JJ Sun and MJ Walker (1986) Actions of cardiotoxins from the southern Chinese cobra (Naja naja atra) on rat cardiac tissue. Toxicon 24(3), 233-245.
197. M Ismail, AM al-Bekairi, AM el-Bedaiwy and MA Abd-el Salam (1993) The ocular effects of spitting cobras: I. The ringhals cobra (Hemachatus haemachatus) venom-induced corneal opacification syndrome. J Toxicol Clin Toxicol 31(1), 31-41.
198. J Tibballs and SK Sutherland (1992) The efficacy of heparin in the treatment of common brown snake (Pseudonaja textilis) envenomation. Anaesth Intensive Care 20(1), 33-37.
199. J Tibballs (1998) The cardiovascular, coagulation and haematological effects of tiger snake (Notechis scutatus) prothrombin activator and investigation of release of vasoactive substances. Anaesth Intensive Care 26(5), 536-547.
200. J Tibballs, SK Sutherland, RA Rivera and PP Masci (1992) The cardiovascular and haematological effects of purified prothrombin activator from the common brown snake (Pseudonaja textilis) and their antagonism with heparin. Anaesth Intensive Care 20(1), 28-32.